What Drug Is Mounjaro? Understanding Tirzepatide

Tirzepatide belongs to a class of medicines that act on incretin hormone receptors. Most GLP-1 medicines target a single pathway; tirzepatide is a dual agonist, activating both the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. To understand what GLP-1 is and how this pathway affects appetite, it helps to know that these are naturally occurring gut hormones involved in signalling fullness and regulating blood sugar after eating.

By activating both receptors, tirzepatide influences several processes that many people on the medicine notice in daily life:

• Reduced appetite and food noise — many people report feeling less preoccupied with food
• Increased sense of fullness — smaller amounts of food may feel more satisfying
• Slower gastric emptying — food moves through the stomach more slowly, which is also a common cause of early nausea on the medicine

These are commonly reported effects, not universal ones — individual responses vary, and your prescriber or doctor is the right person to speak to about what you personally experience.

A question that comes up often is whether Mounjaro is a form of insulin. It is not — for a clear explanation of the difference, see how Mounjaro compares to insulin. Similarly, if you are wondering how tirzepatide differs from semaglutide, the active substance in Wegovy, the key distinction is that mechanism: semaglutide acts on GLP-1 receptors only, whereas tirzepatide acts on both GIP and GLP-1. You can read more about what drug is in Wegovy and how semaglutide relates to Ozempic for further context.

Mounjaro is supplied as a pre-filled injection pen and is taken once weekly. Dose strengths typically referenced in prescribing information include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg — though the dose at any stage of your treatment is determined by your prescriber, not self-selected. For detailed prescribing information, the electronic Medicines Compendium (eMC) holds the full Summary of Product Characteristics for Mounjaro.

Because Mounjaro carries a black triangle (▼) designation, it is subject to additional monitoring. Any suspected side effects should be reported to your healthcare professional and, where applicable, to your national reporting scheme (such as the UK's Yellow Card scheme or the equivalent in your country).

If you are also taking other medicines, it is worth being aware that tirzepatide can affect how some drugs are absorbed — your prescriber or doctor can advise on this, and you can also read about Mounjaro and potential drug interactions.

Understanding what tirzepatide does in the body is one thing — keeping track of how it affects your body week to week is where a tool like GLP Trackr becomes useful.

The most directly relevant feature for someone building familiarity with the medicine is side-effect tracking. Because tirzepatide influences gastric emptying and appetite signals, the effects people notice — nausea, changes in hunger, fatigue, digestive shifts — can vary considerably by dose stage and by week. Logging how you feel after each injection, and seeing those entries laid out over time, often reveals patterns that are worth discussing at your next prescriber appointment.

GLP Trackr also includes a dose and injection log, so every weekly shot is recorded with its date, strength, and injection site. This means you always have an accurate picture of where you are in your treatment schedule — and the app can generate a summary you can bring to your prescriber, rather than trying to recall details from memory.

For a broader picture of how the medicine works and what to expect over time, the full guide to how Mounjaro works covers the mechanism, titration, and what many people experience across the treatment journey.

GLP Trackr does not provide medical advice, and nothing in the app replaces the guidance of your prescriber or doctor — they have your full clinical history and are best placed to interpret what you are experiencing. If any symptom feels severe, persistent, or worrying, contact your healthcare professional promptly rather than relying on an app to assess it.

Want to start connecting what tirzepatide does with what you are actually feeling? GLP Trackr is free to try for 7 days — download it on the App Store or Google Play and log your first week.